Does tumor rupture during robot-assisted partial nephrectomy have an impact on mid-term tumor recurrences?
Catégorie d'article: Research Article
Publié en ligne: 20 juil. 2023
Pages: 348 - 355
Reçu: 19 avr. 2023
Accepté: 23 mai 2023
DOI: https://doi.org/10.2478/raon-2023-0031
Mots clés
© 2023 Simon Hawlina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Background
Intraoperative kidney tumor rupture (TR) can occur during robot-assisted partial nephrectomy (RAPN) in daily clinical practice, but there are no solid guidelines on the management and implications of it. The purpose of the study was to investigate the impact of TR on tumor recurrences, what a surgeon should do if this adverse event occurs, and how to avoid it.
Patients and methods
We retrospectively analyzed the first 100 patients who underwent RAPN at University Medical Centre Ljubljana, between 2018 and 2021. Patients were stratified into 2 groups (TR and no-TR) and were compared according to patient, tumor, pathologic, perioperative and postoperative characteristics and tumor recurrences, using the Mann-Whitney U test and chi-squared test.
Results
Of the 100 patients, 14 had TR (14%); this occurred in tumors with higher RENAL nephrometry scores (P = 0.028) and mostly with papillary renal cell carcinomas (P = 0.043). Median warm ischemia time was longer for the TR group (22
Conclusions
Tumor rupture during RAPN seems to be of no mid-term oncologic importance. According to presented results, we would recommend surgeons to proceed with tumor resection if this event occurs and abstain from conversion to radical nephrectomy or open partial nephrectomy. However, more similar cases should be studied to make more solid conclusions.